Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endothelin Receptor Antagonist Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Ambrisentan
1.2.3 Bosentan
1.2.4 Macitentan
1.3 Market by Application
1.3.1 Global Endothelin Receptor Antagonist Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Mail Order Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endothelin Receptor Antagonist Market Perspective (2018-2034)
2.2 Endothelin Receptor Antagonist Growth Trends by Region
2.2.1 Global Endothelin Receptor Antagonist Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Endothelin Receptor Antagonist Historic Market Size by Region (2018-2023)
2.2.3 Endothelin Receptor Antagonist Forecasted Market Size by Region (2024-2034)
2.3 Endothelin Receptor Antagonist Market Dynamics
2.3.1 Endothelin Receptor Antagonist Industry Trends
2.3.2 Endothelin Receptor Antagonist Market Drivers
2.3.3 Endothelin Receptor Antagonist Market Challenges
2.3.4 Endothelin Receptor Antagonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endothelin Receptor Antagonist Players by Revenue
3.1.1 Global Top Endothelin Receptor Antagonist Players by Revenue (2018-2023)
3.1.2 Global Endothelin Receptor Antagonist Revenue Market Share by Players (2018-2023)
3.2 Global Endothelin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endothelin Receptor Antagonist Revenue
3.4 Global Endothelin Receptor Antagonist Market Concentration Ratio
3.4.1 Global Endothelin Receptor Antagonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endothelin Receptor Antagonist Revenue in 2024
3.5 Endothelin Receptor Antagonist Key Players Head office and Area Served
3.6 Key Players Endothelin Receptor Antagonist Product Solution and Service
3.7 Date of Enter into Endothelin Receptor Antagonist Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endothelin Receptor Antagonist Breakdown Data by Type
4.1 Global Endothelin Receptor Antagonist Historic Market Size by Type (2018-2023)
4.2 Global Endothelin Receptor Antagonist Forecasted Market Size by Type (2024-2034)
5 Endothelin Receptor Antagonist Breakdown Data by Application
5.1 Global Endothelin Receptor Antagonist Historic Market Size by Application (2018-2023)
5.2 Global Endothelin Receptor Antagonist Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Endothelin Receptor Antagonist Market Size (2018-2034)
6.2 North America Endothelin Receptor Antagonist Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Endothelin Receptor Antagonist Market Size by Country (2018-2023)
6.4 North America Endothelin Receptor Antagonist Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endothelin Receptor Antagonist Market Size (2018-2034)
7.2 Europe Endothelin Receptor Antagonist Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Endothelin Receptor Antagonist Market Size by Country (2018-2023)
7.4 Europe Endothelin Receptor Antagonist Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endothelin Receptor Antagonist Market Size (2018-2034)
8.2 Asia-Pacific Endothelin Receptor Antagonist Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2018-2023)
8.4 Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endothelin Receptor Antagonist Market Size (2018-2034)
9.2 Latin America Endothelin Receptor Antagonist Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Endothelin Receptor Antagonist Market Size by Country (2018-2023)
9.4 Latin America Endothelin Receptor Antagonist Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endothelin Receptor Antagonist Market Size (2018-2034)
10.2 Middle East & Africa Endothelin Receptor Antagonist Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2018-2023)
10.4 Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences Inc.
11.1.1 Gilead Sciences Inc. Company Detail
11.1.2 Gilead Sciences Inc. Business Overview
11.1.3 Gilead Sciences Inc. Endothelin Receptor Antagonist Introduction
11.1.4 Gilead Sciences Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023)
11.1.5 Gilead Sciences Inc. Recent Development
11.2 Glaxosmithkline Inc.
11.2.1 Glaxosmithkline Inc. Company Detail
11.2.2 Glaxosmithkline Inc. Business Overview
11.2.3 Glaxosmithkline Inc. Endothelin Receptor Antagonist Introduction
11.2.4 Glaxosmithkline Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023)
11.2.5 Glaxosmithkline Inc. Recent Development
11.3 Sun Pharmaceutical Industries, Inc.
11.3.1 Sun Pharmaceutical Industries, Inc. Company Detail
11.3.2 Sun Pharmaceutical Industries, Inc. Business Overview
11.3.3 Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Introduction
11.3.4 Sun Pharmaceutical Industries, Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023)
11.3.5 Sun Pharmaceutical Industries, Inc. Recent Development
11.4 Mylan Pharmaceuticals Inc.
11.4.1 Mylan Pharmaceuticals Inc. Company Detail
11.4.2 Mylan Pharmaceuticals Inc. Business Overview
11.4.3 Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Introduction
11.4.4 Mylan Pharmaceuticals Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023)
11.4.5 Mylan Pharmaceuticals Inc. Recent Development
11.5 Actavis Pharma, Inc.
11.5.1 Actavis Pharma, Inc. Company Detail
11.5.2 Actavis Pharma, Inc. Business Overview
11.5.3 Actavis Pharma, Inc. Endothelin Receptor Antagonist Introduction
11.5.4 Actavis Pharma, Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023)
11.5.5 Actavis Pharma, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Endothelin Receptor Antagonist Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Ambrisentan
Table 3. Key Players of Bosentan
Table 4. Key Players of Macitentan
Table 5. Global Endothelin Receptor Antagonist Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Endothelin Receptor Antagonist Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Endothelin Receptor Antagonist Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Endothelin Receptor Antagonist Market Share by Region (2018-2023)
Table 9. Global Endothelin Receptor Antagonist Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Endothelin Receptor Antagonist Market Share by Region (2024-2034)
Table 11. Endothelin Receptor Antagonist Market Trends
Table 12. Endothelin Receptor Antagonist Market Drivers
Table 13. Endothelin Receptor Antagonist Market Challenges
Table 14. Endothelin Receptor Antagonist Market Restraints
Table 15. Global Endothelin Receptor Antagonist Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Endothelin Receptor Antagonist Market Share by Players (2018-2023)
Table 17. Global Top Endothelin Receptor Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelin Receptor Antagonist as of 2024)
Table 18. Ranking of Global Top Endothelin Receptor Antagonist Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Endothelin Receptor Antagonist Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Endothelin Receptor Antagonist Product Solution and Service
Table 22. Date of Enter into Endothelin Receptor Antagonist Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Endothelin Receptor Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Endothelin Receptor Antagonist Revenue Market Share by Type (2018-2023)
Table 26. Global Endothelin Receptor Antagonist Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Endothelin Receptor Antagonist Revenue Market Share by Type (2024-2034)
Table 28. Global Endothelin Receptor Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Endothelin Receptor Antagonist Revenue Market Share by Application (2018-2023)
Table 30. Global Endothelin Receptor Antagonist Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Endothelin Receptor Antagonist Revenue Market Share by Application (2024-2034)
Table 32. North America Endothelin Receptor Antagonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Endothelin Receptor Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Endothelin Receptor Antagonist Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Endothelin Receptor Antagonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Endothelin Receptor Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Endothelin Receptor Antagonist Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Endothelin Receptor Antagonist Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Endothelin Receptor Antagonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Endothelin Receptor Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Endothelin Receptor Antagonist Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Endothelin Receptor Antagonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2024-2034) & (US$ Million)
Table 47. Gilead Sciences Inc. Company Detail
Table 48. Gilead Sciences Inc. Business Overview
Table 49. Gilead Sciences Inc. Endothelin Receptor Antagonist Product
Table 50. Gilead Sciences Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023) & (US$ Million)
Table 51. Gilead Sciences Inc. Recent Development
Table 52. Glaxosmithkline Inc. Company Detail
Table 53. Glaxosmithkline Inc. Business Overview
Table 54. Glaxosmithkline Inc. Endothelin Receptor Antagonist Product
Table 55. Glaxosmithkline Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023) & (US$ Million)
Table 56. Glaxosmithkline Inc. Recent Development
Table 57. Sun Pharmaceutical Industries, Inc. Company Detail
Table 58. Sun Pharmaceutical Industries, Inc. Business Overview
Table 59. Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Product
Table 60. Sun Pharmaceutical Industries, Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023) & (US$ Million)
Table 61. Sun Pharmaceutical Industries, Inc. Recent Development
Table 62. Mylan Pharmaceuticals Inc. Company Detail
Table 63. Mylan Pharmaceuticals Inc. Business Overview
Table 64. Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Product
Table 65. Mylan Pharmaceuticals Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023) & (US$ Million)
Table 66. Mylan Pharmaceuticals Inc. Recent Development
Table 67. Actavis Pharma, Inc. Company Detail
Table 68. Actavis Pharma, Inc. Business Overview
Table 69. Actavis Pharma, Inc. Endothelin Receptor Antagonist Product
Table 70. Actavis Pharma, Inc. Revenue in Endothelin Receptor Antagonist Business (2018-2023) & (US$ Million)
Table 71. Actavis Pharma, Inc. Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endothelin Receptor Antagonist Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Endothelin Receptor Antagonist Market Share by Type: 2024 VS 2034
Figure 3. Ambrisentan Features
Figure 4. Bosentan Features
Figure 5. Macitentan Features
Figure 6. Global Endothelin Receptor Antagonist Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Endothelin Receptor Antagonist Market Share by Application: 2024 VS 2034
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Mail Order Pharmacy Case Studies
Figure 11. Endothelin Receptor Antagonist Report Years Considered
Figure 12. Global Endothelin Receptor Antagonist Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Endothelin Receptor Antagonist Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Endothelin Receptor Antagonist Market Share by Region: 2024 VS 2034
Figure 15. Global Endothelin Receptor Antagonist Market Share by Players in 2024
Figure 16. Global Top Endothelin Receptor Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelin Receptor Antagonist as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Endothelin Receptor Antagonist Revenue in 2024
Figure 18. North America Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Endothelin Receptor Antagonist Market Share by Country (2018-2034)
Figure 20. United States Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Endothelin Receptor Antagonist Market Share by Country (2018-2034)
Figure 24. Germany Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Endothelin Receptor Antagonist Market Share by Region (2018-2034)
Figure 32. China Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Endothelin Receptor Antagonist Market Share by Country (2018-2034)
Figure 40. Mexico Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Endothelin Receptor Antagonist Market Share by Country (2018-2034)
Figure 44. Turkey Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Endothelin Receptor Antagonist Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Gilead Sciences Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2018-2023)
Figure 47. Glaxosmithkline Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2018-2023)
Figure 48. Sun Pharmaceutical Industries, Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2018-2023)
Figure 49. Mylan Pharmaceuticals Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2018-2023)
Figure 50. Actavis Pharma, Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed